Prior art describes methods for making whole-plant extracts from the Cannabis plant. Terpenes and cannabinoids are classes of compounds found inherently in those extracts. But, because those extracts contain hundreds of different, and sometimes counteracting, compounds, they are not the most effective treatments for common health issues. Specific terpenes and cannabinoids may be isolated and chosen for their use for specific conditions. Examples of the present invention differ from the prior art by selecting isolated compounds (Like the cannabinoid THC and the terpene Myrcene) and specifically combining them with essential and topical agents to produce targeted treatments.

Prior art describes methods for making whole-plant extracts from the Cannabis plant. Terpenes and cannabinoids are classes of compounds found inherently in those extracts. But, because those extracts contain hundreds of different, and sometimes counteracting, compounds, they are not the most effective treatments for common health issues. Specific terpenes and cannabinoids may be isolated and chosen for their use for specific conditions. Examples of the present invention differ from the prior art by selecting isolated compounds (Like the cannabinoid THC and the terpene Myrcene) and specifically combining them with essential and topical agents to produce targeted treatments.

Disclosed herein are embodiments of cannabis extraction methods, apparatuses for extracting cannabis, and methods of using cannabis extracts.

Disclosed herein are embodiments of cannabis extraction methods, apparatuses for extracting cannabis, and methods of using cannabis extracts.

Compositions for treatment and/or prevention of infertility include a pollen extract and/or a pistil extract primarily obtained from plants belonging to the Pinaceae and/or Poaceae family.

Compositions for treatment and/or prevention of infertility include a pollen extract and/or a pistil extract primarily obtained from plants belonging to the Pinaceae and/or Poaceae family.

The present invention provides compositions and methods that promote wound healing in a subject with a cutaneous injury. In particular, the present invention provides systemic and/or local administration of one or more compositions that cause ganglioside depletion (e.g., glucosylceramide synthase (GCS) inhibitors) for the treatment of cutaneous wounds.

Novel plant products customized to provide a desired, consistent and stable Entourage of Interest (EOI) and processes for making and using the same are provided.

Novel plant products customized to provide a desired, consistent and stable Entourage of Interest (EOI) and processes for making and using the same are provided.

The invention relates to a pharmaceutical composition consisting of snail slime Helix aspersa muller (Cryptomphalus aspersus) (20% to 50%), camomile extract (1-4%), propolis 1l-4%), and pharmaceutically acceptable excipients and/or additives for forming a formulation of low, intermediate or high viscosity (10 to 1000 Pa-s). Said composition is in the form of a lotion, soap, cream or gel, which is embedded in a gauze-type fabric in the form of a plaster that can be applied to lesions caused by the different types of rosacea. The composition can also contain natural extracts such as marigold extract, honey and vegetable oils. The invention also relates to the method for producing the composition and to the use thereof for preparing a medicament or device for preventing, treating or curing lesions caused by rosacea, on the skin of the face or the body.